Benzinga | Jan 20, 2022 06:39AM EST

Rosenblatt Upgrades CME Group to Neutral, Announces $254 Price Target

Rosenblatt analyst Sean Horgan upgrades CME Group (NASDAQ:CME) from Sell to Neutral and announces $254 price target.